Sawtooth Solutions, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Sawtooth Solutions, LLC

$3.64 Billion
Q4 2023

A detailed history of Sawtooth Solutions, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Sawtooth Solutions, LLC holds 9,418 shares of REGN stock, worth $7.95 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

9,418

Previous 8,561 10.01%

Holding current value

$7.95 Million

Previous $7.05 Million 17.4%

% of portfolio

0.23%

Previous 0.23%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 29, 2024	BUY	$775.18 - $881.7 $664,329 - $755,616	857 Added 10.01%	9,418 $8.27 Million
Q3 2023 Oct 19, 2023	SELL	$692.45 - $844.37 $2.37 Million - $2.89 Million	-3,419 Reduced 28.54%	8,561 $7.05 Million
Q2 2023 Jul 26, 2023	BUY	$700.03 - $830.35 $209,308 - $248,274	299 Added 2.56%	11,980 $8.61 Million
Q1 2023 Apr 27, 2023	BUY	$680.49 - $826.97 $7.27 Million - $8.84 Million	10,687 Added 1075.15%	11,681 $9.6 Million
Q4 2022 Feb 02, 2023	SELL	$705.89 - $766.39 $7,058 - $7,663	-10 Reduced 1.0%	994 $717,000
Q3 2022 Oct 12, 2022	BUY	$573.97 - $724.32 $320,849 - $404,894	559 Added 125.62%	1,004 $692,000
Q2 2022 Jul 19, 2022	SELL	$548.35 - $738.84 $185,342 - $249,727	-338 Reduced 43.17%	445 $263,000
Q1 2022 May 20, 2022	SELL	$595.12 - $698.43 $35,112 - $41,207	-59 Reduced 7.01%	783 $547,000
Q4 2021 Feb 11, 2022	BUY	$543.48 - $670.97 $259,239 - $320,052	477 Added 130.68%	842 $532,000
Q3 2021 Nov 09, 2021	BUY	$574.03 - $680.96 $209,520 - $248,550	365 New	365 $221,000
Q1 2021 May 13, 2021	SELL	$446.73 - $548.2 $383,741 - $470,903	-859 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$478.3 - $607.98 $757,148 - $962,432	-1,583 Reduced 64.82%	859 $415,000
Q3 2020 Nov 04, 2020	BUY	$544.75 - $658.21 $36,498 - $44,100	67 Added 2.82%	2,442 $1.37 Million
Q2 2020 Aug 06, 2020	BUY	$493.32 - $643.92 $134,183 - $175,146	272 Added 12.93%	2,375 $1.48 Million
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $415,182 - $610,621	1,235 Added 142.28%	2,103 $1.03 Million
Q3 2019 Nov 07, 2019	BUY	$273.46 - $318.39 $19,689 - $22,924	72 Added 9.05%	868 $241,000
Q2 2019 Aug 08, 2019	BUY	$299.6 - $414.82 $238,481 - $330,196	796 New	796 $249,000
Q4 2018 Feb 13, 2019	SELL	$335.82 - $403.04 $262,611 - $315,177	-782 Closed	0 $0
Q3 2018 Oct 26, 2018	SELL	$351.14 - $408.51 $24,228 - $28,187	-69 Reduced 8.11%	782 $316,000
Q2 2018 Aug 10, 2018	BUY	$284.6 - $344.99 $62,042 - $75,207	218 Added 34.44%	851 $294,000
Q1 2018 May 08, 2018	BUY	$315.82 - $393.78 $199,914 - $249,262	633 New	633 $218,000

Others Institutions Holding REGN

# of Institutions

1,480

Shares Held

85.7M

Call Options Held

908K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $90.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawtooth Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sawtooth Solutions, LLC with notifications on news.

Account

Sawtooth Solutions, LLC Regeneron Pharmaceuticals, Inc. Transaction History